Abstract

The world’s leading causes of mortality and morbidity are cardiovascular diseases (CVDs). The early and long-term effects on patients vary widely despite recent advancements in the management of CVDs, particularly given the difficulties in diagnosing and treating CVDs now. The use of nanoparticles combined formulation to treat illnesses and improve health is made possible by nanotechnology. The dispersion of therapeutic substances in the body is changed by the site-specific, goal-oriented delivery and controlled drug release of precision medicines offered by nanoparticle-based “drug delivery systems (DDS)”. Nanoparticles made of metal, lipid, and polymer are the perfect substances to use in cardiovascular treatments. Significantly, in recent years, researchers have found that nanotechnologies may be useful for treating chronic illnesses, particularly cardiovascular disease (CVD). Various approaches to using nanoparticles and their formulation as drug delivery vehicles in CVDs have been put forth; however, disagreements over the choice of nanomaterials and their formulation are delaying their practical application. In order to provide a safer and more effective method for treating CVD, this review concentrates on a nano-based formulation for drug delivery and its therapeutic function.

Description